Selenium slows prostate cancer progression
NT Online Clinical News
posted on 05 05 2004
Source: NPI center
High plasma levels of selenium may slow disease progression in prostate cancer, according to new research.
A paper published in the Journal of the National Cancer Institute analysed data from men enrolled in the Physicians' Health Study.
Baseline selenium levels obtained in 1982 from 586 men diagnosed with prostate cancer during 13 years of follow-up were compared with levels from 577 control subjects.
Men in the highest selenium level quintile were 48% less likely to develop advanced prostate cancer than men in lowest quintile.
Reference: Li H et al (2004) A Prospective Study of Plasma Selenium Levels and Prostate Cancer Risk J Natl Cancer Inst 96 (9) 696-703.
